Scientists have discovered that cats develop dementia with striking parallels to human Alzheimer's disease,potentially unlocking critical research advancements.Experts at the University of Edinburgh conducted postmortem brain analyses of 25 cats showing dementia symptoms—such as disorientation,disrupted sleep,and increased vocalization—to pioneer novel human treatments.

Unlike genetically modified rodents(which don't naturally experience dementia),affected feline brains exhibited amyloid-beta accumulation—a toxic protein hallmark of Alzheimer's.This"perfect natural model"revealed synaptic amyloid-beta buildup in older cats,offering unprecedented clarity on how these deposits drive cognitive decline and memory loss.Synapses,essential for neural communication,deteriorate in both feline dementia and human Alzheimer's,impairing mental function.

Crucially,researchers identified astrocytes and microglia(brain support cells)engulfing damaged synapses—a process called synaptic pruning.While vital during development,aberrant pruning contributes to dementia pathology.

Dr.Robert McGeachan,lead researcher from Edinburgh's Royal(Dick)School of Veterinary Studies,emphasized:"Dementia devastates humans and pets alike.Our work underscores remarkable feline-human parallels,enabling exploration of human Alzheimer's therapies for aging cats.Cats'natural disease progression offers superior accuracy over lab animals,benefiting both species and caregivers."

Professor Danielle Gunn-Moore added:"Feline dementia causes profound distress.Studies like this illuminate optimal treatments—transformative for cats,owners,Alzheimer's patients,and families.This natural model is scientifically invaluable:everyone gains."

Funded by Wellcome and the UK Dementia Research Institute,the breakthrough study appears in the European Journal of Neuroscience,with collaborators from Edinburgh,California,and Scottish Brain Sciences.